TrialAntimicrobial agents and chemotherapy2005

Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.

S Etuaful et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.